Inventor · disambiguated record
Francis Descamps
Also filed as: DESCAMPS FRANCIS
10 granted patents·4 pending applications·63 citations·filing 2010–2024
85Inventor score
Top patents by PatentIndex Score
14 records- 0194US11426468B2Cysteine linked nanobody dimersABLYNX NV·Filed 2015·Granted Aug 30, 2022·14 cites·6 claims
- 0290US8937164B2Biological materials related to CXCR7DESCAMPS FRANCIS·Filed 2011·Granted Jan 20, 2015·38 cites·14 claims
- 0385US11021544B2Nanobody dimers linked via C-terminally engineered cysteinsABLYNX NV·Filed 2016·Granted Jun 1, 2021·4 cites·21 claims
- 0483US12129308B2MMP13 binding immunoglobulinsMERCK PATENT GMBH·Filed 2018·Granted Oct 29, 2024·2 cites·16 claims
- 0576US2025129183A1Mmp13 binding immunoglobulinsMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 0675US10618964B2Nanobody against IL-6RCOMPERNOLLE VEERLE·Filed 2010·Granted Apr 14, 2020·5 cites·4 claims
- 0769US12384835B2Cysteine linked nanobody dimersABLYNX NV·Filed 2022·Granted Aug 12, 2025·0 cites·19 claims
- 0868US2025236673A1Protein-based carriers for site-specific amine conjugationABLYNX NV·Filed 2024·Application pending·0 cites
- 0957US9994639B2Biological materials related to CXCR7ABLYNX NV·Filed 2013·Granted Jun 12, 2018·0 cites·8 claims
- 1057US9758584B2Biological materials related to CXCR7ABLYNX NV·Filed 2014·Granted Sep 12, 2017·0 cites·20 claims
- 1153US2018355048A1Biological materials related to cxcr7ABLYNX NV·Filed 2018·Application pending·0 cites
- 1247US2015158948A9Bispecific anti-cxcr7 immunoglobulin single variable domainsDESCAMPS FRANCIS·Filed 2012·Application pending·0 cites
- 1342US9512236B2Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disordersABLYNX NV·Filed 2012·Granted Dec 6, 2016·0 cites·4 claims
- 1432US11149086B2KV1.3 binding immunoglobulinsABLYNX NV·Filed 2015·Granted Oct 19, 2021·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Francis Descamps files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →